Status:
COMPLETED
Comparison on Efficacy and Safety of Three Inpatient Insulin Therapy in Type2 DM
Lead Sponsor:
Cairo University
Conditions:
Diabetes Mellitus (DM)
Eligibility:
All Genders
18-64 years
Phase:
NA
Brief Summary
Purpose: To compare efficacy and safety of traditional sliding scale insulin (SSI) versus modified 70/30 insulin versus modified basal plus supplemental scale /bolus insulin regimens for glycemic cont...
Eligibility Criteria
Inclusion
- known history of type 2 DM for longer than 3 months
- age between 18-64 year old,
- treatment with diet alone, any combination of oral antidiabetic agents and/or insulin before admission.
Exclusion
- subjects with hyperglycemia without any known history of DM
- presence of diabetic ketoacidosis (DKA)
- patients admitted to intensive care unit (ICU)
- subjects expected to undergo surgery during the hospitalization course
- patients with clinically relevant hepatic disease impaired renal function (serum creatinine ≥ 3.0 mg/dL) systemic infections pregnancy patients on medications known to interfere with the blood glucose level (either increasing or decreasing
Key Trial Info
Start Date :
March 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2014
Estimated Enrollment :
63 Patients enrolled
Trial Details
Trial ID
NCT01855243
Start Date
March 1 2010
End Date
June 1 2014
Last Update
January 15 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
the department of internal medicine, Cairo University teaching hospitals,
Cairo, Egypt